Laurent Ferradini

Summary

Affiliation: Phnom Penh
Country: Cambodia

Publications

  1. ncbi request reprint Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment
    Laurent Ferradini
    Epicentre, Paris, France
    Lancet 367:1335-42. 2006
  2. pmc Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda
    Francesco Checchi
    Epicentre, Paris, France
    Malar J 5:59. 2006
  3. ncbi request reprint Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia
    Laurent Ferradini
    Epicentre, Paris, France
    AIDS 21:2293-301. 2007
  4. doi request reprint Prevalence, risk factors, and impact on outcome of cytomegalovirus replication in serum of Cambodian HIV-infected patients (2004-2007)
    Romain Micol
    Unité d Epidémiologie des Maladies Emergentes, Institut Pasteur, Paris, France
    J Acquir Immune Defic Syndr 51:486-91. 2009
  5. doi request reprint Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV-infected patients in Cambodia
    Mar Pujades-Rodriguez
    Epicentre, Paris, France
    Trop Med Int Health 16:205-13. 2011
  6. pmc Prevalence study of yaws in the Democratic Republic of Congo using the lot quality assurance sampling method
    Sibylle Gerstl
    Epicentre, Paris, France
    PLoS ONE 4:e6338. 2009
  7. ncbi request reprint Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients
    Romain Micol
    Unité d Epidémiologie des Maladies Emergentes, Institut Pasteur, Paris, France
    J Acquir Immune Defic Syndr 45:555-9. 2007
  8. pmc Increased risk of Q151M and K65R mutations in patients failing stavudine-containing first-line antiretroviral therapy in Cambodia
    Janin Nouhin
    HIV Hepatitis Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia Université Paris Diderot, Sorbonne Paris Cité, Paris, France
    PLoS ONE 8:e73744. 2013
  9. ncbi request reprint Reverse transcriptase mutations in Cambodian CRF01_AE isolates after antiretroviral prophylaxis against HIV Type 1 perinatal transmission
    Nary Ly
    Institut Pasteur du Cambodge, Phnom Penh, Cambodia
    AIDS Res Hum Retroviruses 23:1563-8. 2007
  10. ncbi request reprint Characterization of mutations in HIV type 1 isolates from 144 Cambodian recently infected patients and pregnant women naive to antiretroviral drugs
    Nary Ly
    Institut Pasteur du Cambodge, BP983, Phnom Penh, Cambodia
    AIDS Res Hum Retroviruses 21:971-6. 2005

Collaborators

Detail Information

Publications12

  1. ncbi request reprint Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment
    Laurent Ferradini
    Epicentre, Paris, France
    Lancet 367:1335-42. 2006
    ..We aimed to assess the effectiveness of such a programme held by Médecins Sans Frontières (MSF) in the Chiradzulu district, Malawi...
  2. pmc Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda
    Francesco Checchi
    Epicentre, Paris, France
    Malar J 5:59. 2006
    ....
  3. ncbi request reprint Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia
    Laurent Ferradini
    Epicentre, Paris, France
    AIDS 21:2293-301. 2007
    ..We report the outcomes at 24 months of antiretroviral therapy (ART) in patients treated in a Médecins Sans Frontières/Ministry of Health programme in Cambodia...
  4. doi request reprint Prevalence, risk factors, and impact on outcome of cytomegalovirus replication in serum of Cambodian HIV-infected patients (2004-2007)
    Romain Micol
    Unité d Epidémiologie des Maladies Emergentes, Institut Pasteur, Paris, France
    J Acquir Immune Defic Syndr 51:486-91. 2009
    ..We estimated the prevalence of replicating CMV in sera of newly diagnosed HIV-infected Cambodian patients and examined its impact on mortality...
  5. doi request reprint Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV-infected patients in Cambodia
    Mar Pujades-Rodriguez
    Epicentre, Paris, France
    Trop Med Int Health 16:205-13. 2011
    ..To report immunovirological outcomes and resistance patterns in adults treated with triple combination antiretroviral therapy (cART) for 4 years in an HIV programme of Phnom Penh, Cambodia...
  6. pmc Prevalence study of yaws in the Democratic Republic of Congo using the lot quality assurance sampling method
    Sibylle Gerstl
    Epicentre, Paris, France
    PLoS ONE 4:e6338. 2009
    ..We carried out a survey to estimate the village-level prevalence of yaws in the region of Equator in the north of the country in order to define appropriate strategies to effectively treat the affected population...
  7. ncbi request reprint Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients
    Romain Micol
    Unité d Epidémiologie des Maladies Emergentes, Institut Pasteur, Paris, France
    J Acquir Immune Defic Syndr 45:555-9. 2007
    ..To determine the prevalence, determinants ofpositivity, and clinical utility of serum cryptococcal polysaccharide (CPS) antigen testing among HIV-infected patients in 2004 in Cambodia, an area highly endemic for cryptococcosis...
  8. pmc Increased risk of Q151M and K65R mutations in patients failing stavudine-containing first-line antiretroviral therapy in Cambodia
    Janin Nouhin
    HIV Hepatitis Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia Université Paris Diderot, Sorbonne Paris Cité, Paris, France
    PLoS ONE 8:e73744. 2013
    ....
  9. ncbi request reprint Reverse transcriptase mutations in Cambodian CRF01_AE isolates after antiretroviral prophylaxis against HIV Type 1 perinatal transmission
    Nary Ly
    Institut Pasteur du Cambodge, Phnom Penh, Cambodia
    AIDS Res Hum Retroviruses 23:1563-8. 2007
    ..No apparent subtype-specific treatment-related mutations were detected. NNRTI RM occurrence in CRF01_AE strains is similar to subtype A, D, and CRF02_AG strains after exposure to antiretroviral drugs for PMTCT...
  10. ncbi request reprint Characterization of mutations in HIV type 1 isolates from 144 Cambodian recently infected patients and pregnant women naive to antiretroviral drugs
    Nary Ly
    Institut Pasteur du Cambodge, BP983, Phnom Penh, Cambodia
    AIDS Res Hum Retroviruses 21:971-6. 2005
    ..Five other strains carried drug resistance mutations to RTIs: K70R (one strain), V75M (three strains), and K101E (one strain). Of the isolates 4.9% had drug resistance mutations to antiretroviral drugs...
  11. ncbi request reprint HIV-specific antibodies but not t-cell responses are associated with protection in seronegative partners of HIV-1-infected individuals in Cambodia
    Marie Nguyen
    Institut Pasteur du Cambodge, Phnom Penh, Cambodia
    J Acquir Immune Defic Syndr 42:412-9. 2006
    ..Whereas T-cell specific immunity was not associated to protection, our results suggest that HIV-specific humoral immunity and reduced cell susceptibility to infection may contribute to protection against HIV-1 infection in Cambodian EUs...
  12. ncbi request reprint Mycobacterium tuberculosis recall antigens suppress HIV-1 replication in anergic donor cells via CD8+ T cell expansion and increased IL-10 levels
    Shahin Ranjbar
    Center for Blood Research and Department of Medicine, Harvard Medical School, Boston, MA 02115, USA
    J Immunol 172:1953-9. 2004
    ..Therefore, immunotherapeutic approaches aimed at recapitulating Ag-specific MTb anergy in vivo could result in novel and effective approaches to inhibit HIV-1 disease progression in MTb/HIV-1 coinfection...